Given the aggressiveness of the tumors seen in certain germline mutations (specifically HLRCC and SDH-deficient tumors), we routinely perform a local regional lymph node dissection at time of surgery in these settings for larger or more complex solid tumors, even in the setting of preoperatively normal lymph nodes. This evidence concerns the gene SDHB and hereditary leiomyomatosis and renal cell cancer.